Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Orthofix MedicalOFIX -1.85%57 Price-to-Tangible-Book is 2.38 as of Aug. 21, 2026, which is 27% below its 10-year median of 3.26. GuruFocus rates OFIX with a GF Score™ of 57/100 and a GF Value™ of $13.93 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 698 Medical Devices & Instruments companies, Orthofix Medical ranks better than 52.72% on this metric.
The historical rank and industry rank for Orthofix Medical's Price-to-Tangible-Book or its related term are showing as below:
OFIX'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.58 Med: 3.26 Max: 5.51
Current: 2.38
During the past 13 years, Orthofix Medical's highest Price to Tangible Book Ratio was 5.51. The lowest was 1.58. And the median was 3.26.
OFIX's Price-to-Tangible-Book is ranked better than 52.72% of 698
companies
in the Medical Devices & Instruments industry
Industry Median: 2.7
vs OFIX: 2.38
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Orthofix Medical Price-to-Tangible-Book Related Terms
Orthofix Medical Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for Orthofix Medical's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OFIX vs VMD, VREX, KIDS: Price-to-Tangible-Book Comparison
For the Medical Devices subindustry, Orthofix Medical's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orthofix Medical Price-to-Tangible-Book vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Orthofix Medical's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Orthofix Medical's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Orthofix Medical (OFIX) has a Price-to-Tangible-Book of 2.38 as of Aug. 21, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Orthofix Medical and its competitors. This is 27% below median its historical median of 3.26. Over the past decade, Orthofix Medical's Price-to-Tangible-Book has ranged from 1.58 to 5.51. According to the industry distribution chart, Orthofix Medical ranks #330 out of 698 companies in the Medical Devices & Instruments industry, placing it in the top 47.3%.
Is Orthofix Medical's Price-to-Tangible-Book too high?
Orthofix Medical's current Price-to-Tangible-Book of 2.38 is 27% below median its 10-year median of 3.26. Over the past 10 years, this metric has ranged from a low of 1.58 to a high of 5.51. The Medical Devices & Instruments industry median Price-to-Tangible-Book is 2.70. Orthofix Medical's value of 2.38 is 11.9% below this industry median. Based on the distribution chart, Orthofix Medical ranks #330 out of 698 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Orthofix Medical has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Orthofix Medical's Price-to-Tangible-Book compare to VMD and VREX?
According to the Medical Devices & Instruments industry distribution chart, Orthofix Medical ranks #330 out of 698 companies for Price-to-Tangible-Book. This puts Orthofix Medical in the upper half of its industry. The industry median Price-to-Tangible-Book is 2.70. Orthofix Medical's value of 2.38 is 11.9% below this benchmark. Historically, Orthofix Medical's own Price-to-Tangible-Book has ranged from 1.58 to 5.51 over the past decade. While the company's 10-year median is 3.26 vs. the industry median of 2.70, Orthofix Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Medical Devices & Instruments company?
The median Price-to-Tangible-Book among Medical Devices & Instruments companies is 2.70, based on 698 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orthofix Medical's current Price-to-Tangible-Book of 2.38 is 11.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Orthofix Medical and its competitors. For the Medical Devices & Instruments industry, the median Price-to-Tangible-Book is 2.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orthofix Medical's current Price-to-Tangible-Book is 2.38, which is 27% below median its own 10-year median of 3.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orthofix Medical stock overvalued right now?
Based on GuruFocus' analysis, Orthofix Medical (OFIX) is currently considered Modestly Undervalued. The stock's GF Value™ is $13.93, compared to a current price of $9.83 — trading 29.5% below its estimated fair value. The current Price-to-Tangible-Book is 2.38, which is 27% below median its 10-year median of 3.26 and 11.9% below the Medical Devices & Instruments industry median of 2.70. Orthofix Medical's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Orthofix Medical (OFIX), the current Price-to-Tangible-Book is 2.38 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orthofix Medical (OFIX) Overvalued in 2026?
Based on GuruFocus' analysis, Orthofix Medical stock appears to be undervalued.
The current stock price of $9.83 is trading 29.5% below its estimated GF Value™ of $13.93.
GuruFocus considers Orthofix Medical to be Modestly Undervalued.
Key valuation signals for OFIX:
Price-to-Tangible-Book: 2.38 (27% below median its 10-year median of 3.26)
GF Value™: $13.93 vs. price of $9.83 (29.5% below fair value)
Industry Position: 11.9% below the Medical Devices & Instruments median (#330 of 698)
No single metric tells the full story. See the OFIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
57GF Score
Get the complete analysis for OFIX
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OFIX has been successfully added to your 
